Researchers report that a combination of 3 medicinesaspirin, blood pressure-lowering beta-blockers, and cholesterol-lowering statinsmay more effectively improve the chances of survival for patients with heart disease than any of those taken alone. A study conducted at the University of Nottingham, England, showed that the combination resulted in an 83% reduction in deaths among these patients. The study is the first large-scale, long-term trial to find different drug combinations effective in the reduction of the risk of death in patients with heart disease. Experts have previously believed that a statin-aspirin-beta-blocker combination, along with folic acid, should be developed into a single pill that could be taken by all seniors 55 and older. Although the study suggests that such a pill could help patients with preexisting heart disease, there is no evidence to suggest that this pill should be prescribed for all seniors.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs